What does CUSIP 019770106 represent in this 13F holders report?

CUSIP 019770106 is the security identifier for ALLO - Allogene Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held ALLO - Allogene Therapeutics, Inc. - Common Stock in Q2 2021?

175 institutional investors reported ALLO - Allogene Therapeutics, Inc. - Common Stock for Q2 2021. Use the holders table for investor-level position and value details.

Allogene Therapeutics, Inc. - Common Stock (ALLO)

CUSIP: 019770106

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock
Shares outstanding: 228,416,724
Total 13F shares: 86,340,537
Share change: -2,028,418
Total reported value: $2,251,293,398
Put/Call ratio: 99%
Price per share: $26.08
Number of holders: 175
Value change: -$84,504,708
Number of buys: 118
Number of sells: 55

Quarterly Holders Quick Answers

What is CUSIP 019770106?
CUSIP 019770106 identifies ALLO - Allogene Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 019770106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ALLO - Allogene Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
TPG Group Holdings (SBS) Advisors, Inc.	13F	Company	8.2%	18,716,306	$660,686,000	—	31 Mar 2021	13F
Capital Research Global Investors	13F	Company	5.5%	12,664,013	$447,040,000	—	31 Mar 2021	13F
Capital International Investors	13F	Company	2.9%	6,599,036	$232,946,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	2.7%	6,270,078	$221,334,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	2.6%	5,956,693	$210,271,000	—	31 Mar 2021	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.5%	3,456,753	$122,023,000	—	31 Mar 2021	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	1.1%	2,541,559	$89,717,000	—	31 Mar 2021	13F
JPMORGAN CHASE & CO	13F	Company	1%	2,381,867	$84,080,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	1%	2,333,796	$82,383,000	—	31 Mar 2021	13F
Capital World Investors	13F	Company	0.98%	2,246,603	$79,305,000	—	31 Mar 2021	13F
Wildcat Capital Management, LLC	13F	Company	0.66%	1,515,524	$53,498,000	—	31 Mar 2021	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	0.57%	1,305,400	$46,081,000	—	31 Mar 2021	13F
Casdin Capital, LLC	13F	Company	0.57%	1,300,000	$45,890,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.56%	1,281,078	$45,222,000	—	31 Mar 2021	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.5%	1,143,790	$40,376,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.47%	1,072,831	$37,870,000	—	31 Mar 2021	13F
NORGES BANK	13F	Company	0.42%	960,171	$33,894,000	—	31 Mar 2021	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.42%	948,859	$33,494,000	—	31 Mar 2021	13F
HHLR ADVISORS, LTD.	13F	Company	0.35%	800,000	$28,240,000	—	31 Mar 2021	13F
Of The University Of California Regents	13F	Individual	0.3%	675,743	$23,854,000	—	31 Mar 2021	13F
Woodline Partners LP	13F	Company	0.29%	672,644	$23,744,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.28%	648,464	$22,890,000	—	31 Mar 2021	13F
PFM Health Sciences, LP	13F	Company	0.26%	590,378	$20,840,000	—	31 Mar 2021	13F
FMR LLC	13F	Company	0.25%	565,491	$19,962,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.25%	563,054	$19,876,000	—	31 Mar 2021	13F
Lombard Odier Asset Management (Switzerland) SA	13F	Company	0.23%	536,738	$18,947,000	—	31 Mar 2021	13F
Lombard Odier SCmA Compagnie	13F	Individual	0.23%	536,738	$18,947,000	—	31 Mar 2021	13F
HealthCor Management, L.P.	13F	Company	0.22%	494,640	$17,461,000	—	31 Mar 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.18%	414,100	$14,618,000	—	31 Mar 2021	13F
Cerity Partners LLC	13F	Company	0.18%	401,602	$14,177,000	—	31 Mar 2021	13F
Coastal Bridge Advisors, LLC	13F	Company	0.13%	303,240	$10,704,000	—	31 Mar 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.12%	282,965	$9,989,000	—	31 Mar 2021	13F
Pier Capital, LLC	13F	Company	0.12%	273,646	$9,660,000	—	31 Mar 2021	13F
MOORE CAPITAL MANAGEMENT, LP	13F	Company	0.11%	248,466	$8,771,000	—	31 Mar 2021	13F
EATON VANCE MANAGEMENT	13F	Company	0.1%	237,353	$8,379,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.1%	228,049	$8,050,000	—	31 Mar 2021	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.1%	225,491	$7,908,084	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	0.1%	222,149	$7,841,000	—	31 Mar 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.09%	199,951	$7,058,000	—	31 Mar 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.08%	192,538	$6,797,000	—	31 Mar 2021	13F
DSAM Partners (London) Ltd	13F	Company	0.08%	185,142	$6,536,000	—	31 Mar 2021	13F
NORDEA INVESTMENT MANAGEMENT AB	13F	Company	0.07%	168,983	$5,928,000	—	31 Mar 2021	13F
Mirae Asset Global Investments Co., Ltd.	13F	Company	0.07%	156,053	$5,509,000	—	31 Mar 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.07%	154,250	$5,445,000	—	31 Mar 2021	13F
MACQUARIE GROUP LTD	13F	Company	0.06%	148,329	$5,236,000	—	31 Mar 2021	13F
Swiss National Bank	13F	Company	0.06%	144,200	$5,090,000	—	31 Mar 2021	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.06%	138,328	$4,883,000	—	31 Mar 2021	13F
BARCLAYS PLC	13F	Company	0.06%	129,518	$4,571,000	—	31 Mar 2021	13F
CITIGROUP INC	13F	Company	0.05%	123,961	$4,376,000	—	31 Mar 2021	13F
Capital Bank & Trust Co	13F	Company	0.05%	120,456	$4,252,000	—	31 Mar 2021	13F

Institutional Holders of Allogene Therapeutics, Inc. - Common Stock (ALLO) as of Q2 2021

As of 30 Jun 2021, Allogene Therapeutics, Inc. - Common Stock (ALLO) was held by 175 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 86,340,537 shares. The largest 10 holders included TPG Group Holdings (SBS) Advisors, Inc., BlackRock Inc., VANGUARD GROUP INC, Capital Research Global Investors, PRIMECAP MANAGEMENT CO/CA/, PRICE T ROWE ASSOCIATES INC /MD/, Capital International Investors, ALLIANCEBERNSTEIN L.P., STATE STREET CORP, and JPMORGAN CHASE & CO. This page lists 176 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

167

Q2 2021 holders

175

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.